# Epoetin beta

## Recormon inj 2000IU(限洗腎室用)

| TAH Drug Code      | [IRECB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IRECB                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of anaemia associated w/ chronic renal failure (CRF) in patients on dialysis; treatment of symptomatic renal anaemia in patient not yet undergoing dialysis. Treatment of symptomatic anaemia in adult patients w/ non-myeloid malignancies receving chemotherapy. Increasing the yield of autologous blood from patients in pre-donation programmes. Prevention of anaemia in premature infant (<34 wk; 750-1,500 g birth wt).                                                            |
| Dosing             | Anaemia with CRF: (Initially)SC, 3 x 20 IU/kg/week , if the increase of hemoglobin level is inadequate (<0.25g/dL per week), may be increased every 4 week by 3 x 20 IU/kg/week; IV, 3 x 40 IU/kg, may up to 80 IU/kg after 4 weeks, 3 times a week. (Maintenance) Half of initial dose, depend on individuals. Symptomatic anemia in patients with tumors/Multiple myeloma/Low grade non-Hodgkin’s lymphoma/Chronic lymphocytic leukemia: Initial dose of 450 IU/kg/week, may up to 900 IU/kg/week. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity. Poorly controlled HTN. Patients, who in the mth preceding treatment, have suffered a MI or stroke. Unstable angina pectoris. Patients at risk of DVT.                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Increased BP, increased platelet count, encephalopathy-like symptoms, thromboembolic event, rash, pruritus, urticaria or inj site reactions.                                                                                                                                                                                                                                                                                                                                                         |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/epoetin-beta-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                          |

